Coherus Oncology, Inc. SEC filings CHRS
Coherus Oncology, Inc. has 921 filings in SEC EDGAR's recent list, going back to Feb 23, 2011. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 28, 2026 | — |
| 424B3 | Prospectus | Aug 28, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 424B5 | Prospectus supplement | Feb 13, 2026 | — |
| 424B5 | Prospectus supplement | Feb 12, 2026 | — |
| 424B5 | Prospectus supplement | Jan 23, 2026 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| S-8 | Employee stock plan registration | Nov 13, 2025 | — |
| S-8 | Employee stock plan registration | Aug 8, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 424B5 | Prospectus supplement | Sep 12, 2023 | — |
| 424B3 | Prospectus | Jul 26, 2023 | — |
| S-4/A | Filing | Jul 24, 2023 | — |
| S-4 | Registration for a merger or exchange | Jul 7, 2023 | — |
| 424B5 | Prospectus supplement | May 17, 2023 | — |
| 424B5 | Prospectus supplement | May 16, 2023 | — |
| S-8 | Employee stock plan registration | Jan 18, 2023 | — |
| 424B5 | Prospectus supplement | Nov 18, 2022 | — |
| S-3 | Shelf registration | Nov 8, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| S-8 | Employee stock plan registration | Jan 13, 2022 | — |
| S-8 | Employee stock plan registration | Jan 4, 2021 | — |
| S-8 | Employee stock plan registration | Jan 4, 2021 | — |
| S-8 | Employee stock plan registration | Jan 24, 2020 | — |
| S-8 | Employee stock plan registration | Jan 24, 2020 | — |
| S-8 | Employee stock plan registration | Nov 8, 2019 | — |
| S-8 | Employee stock plan registration | May 9, 2019 | — |
| S-8 | Employee stock plan registration | Feb 1, 2019 | — |
| S-8 | Employee stock plan registration | Feb 1, 2019 | — |
| S-8 | Employee stock plan registration | Nov 8, 2018 | — |
| S-8 | Employee stock plan registration | Jun 14, 2018 | — |
| 424B5 | Prospectus supplement | May 23, 2018 | — |
| 424B5 | Prospectus supplement | May 21, 2018 | — |
| S-3/A | Filing | May 4, 2018 | — |
| S-8 | Employee stock plan registration | Jan 25, 2018 | — |
| S-3 | Shelf registration | Jan 25, 2018 | — |
| S-3 | Shelf registration | Sep 22, 2017 | — |
| S-8 | Employee stock plan registration | Mar 14, 2017 | — |
| 424B5 | Prospectus supplement | Feb 8, 2017 | — |
| 424B5 | Prospectus supplement | Feb 7, 2017 | — |
| 424B5 | Prospectus supplement | Oct 28, 2016 | — |
| S-8 | Employee stock plan registration | Aug 11, 2016 | — |
| 424B5 | Prospectus supplement | May 24, 2016 | — |
| 424B5 | Prospectus supplement | May 23, 2016 | — |
| S-8 | Employee stock plan registration | Mar 4, 2016 | — |
| S-3 | Shelf registration | Dec 18, 2015 | — |
| S-8 | Employee stock plan registration | Apr 10, 2015 | — |
| 424B4 | Prospectus | Apr 1, 2015 | — |
| S-1MEF | Filing | Mar 31, 2015 | — |
| S-1/A | Amended registration statement | Mar 30, 2015 | — |
| S-1 | Registration statement | Mar 23, 2015 | — |
| S-8 | Employee stock plan registration | Nov 25, 2014 | — |
| 424B4 | Prospectus | Nov 6, 2014 | — |
| S-1/A | Amended registration statement | Nov 6, 2014 | — |
| FWP | Free writing prospectus | Nov 6, 2014 | — |
| S-1/A | Amended registration statement | Nov 4, 2014 | — |
| FWP | Free writing prospectus | Nov 4, 2014 | — |
| S-1/A | Amended registration statement | Oct 24, 2014 | — |
| S-1/A | Amended registration statement | Oct 20, 2014 | — |
| S-1/A | Amended registration statement | Oct 6, 2014 | — |
| S-1 | Registration statement | Sep 25, 2014 | — |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CHRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1512762
- Former names
- Coherus BioSciences, Inc. (until May 28, 2025); BioGenerics, Inc. (until Jan 3, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.